Apellis Pharmaceuticals, Inc. short interest in 2020
In 2020, Apellis Pharmaceuticals, Inc.'s disclosed short interest ran from 13.32% of shares outstanding on 15 Jul 2020 to 11.93% on 31 Dec 2020, a change of -1.39 percentage points. The year's high was 14.41% on 30 Sep 2020 and its low 11.14% on 15 Dec 2020, averaging 13.15% across 12 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 24.90 days on 31 Aug 2020. Full history: Apellis Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 13.32% (15 Jul 2020)
- End of year
- 11.93% (31 Dec 2020)
- Change
- -1.39 pp
- High
- 14.41% (30 Sep 2020)
- Low
- 11.14% (15 Dec 2020)
- Average
- 13.15%
- Highest days to cover
- 24.90 (31 Aug 2020)
- SEC filings marked
- 5
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jul 2020 | 13.32% | 19.12 | results (8-K), 10-K filed, 10-Q filed |
| 31 Jul 2020 | 13.41% | 12.59 | 10-Q filed |
| 14 Aug 2020 | 13.50% | 18.14 | |
| 31 Aug 2020 | 13.63% | 24.90 | |
| 15 Sep 2020 | 13.89% | 21.05 | |
| 30 Sep 2020 | 14.41% | 19.37 | |
| 15 Oct 2020 | 14.08% | 21.86 | |
| 30 Oct 2020 | 13.46% | 21.78 | |
| 13 Nov 2020 | 13.12% | 17.20 | 10-Q filed |
| 30 Nov 2020 | 11.94% | 14.97 | |
| 15 Dec 2020 | 11.14% | 10.97 | |
| 31 Dec 2020 | 11.93% | 12.93 |
See also: Apellis Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.